Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
KordaMentha
The residential aged care industry is likely to continue to grow as an ageing population drives demand for its services.
HopgoodGanim
A health authority owes no duty of care to relatives of a person murdered by a mentally ill patient after his release.
Holding Redlich
The Charter will provide a voluntary and transparent regime for the quick and equitable resolution of any disputes.
Ropes & Gray LLP
On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.
King & Wood Mallesons
Reflections focus on the topics of: response time; response attitude; internal PR teams and official press conferences.
Ropes & Gray LLP
The Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.
Broad & Bright
People are growing increasingly conscientious about their health, and the pharmaceutical industry has become an important part of the national economy.
Ropes & Gray LLP
China’s health authority, the National Health and Family Planning Commission, released the Administrative Measures for the Clinical Study Projects of Medical Institutions.
Foley & Lardner
This post is the second in Foley’s blogs on China telemedicine and the first in the blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We hope to expand the series to include additional issues.
Foley & Lardner
Telemedicine providers and vendors doing business in China, whether based in China, the United States, or elsewhere, received new guidance on the use of telemedicine.
Jones Day
Two individuals will be prosecuted shortly in Shanghai for conducting illegal investigations and purchase of personal information in China.
Jones Day
China continues to struggle in its efforts to improve food safety regulation and oversight, in the wake of a succession of food safety problems.
Ropes & Gray LLP
The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime.
King & Wood Mallesons
This newsletter discusses the differences between the Amendment and the Revised Amendment, and the underlying rationale.
DaHui Lawyers
A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
Eiger
This article outlines the implications of the new Free Trade Agreement between China and Switzerland in relation to the trade in medical devices.
King & Wood Mallesons
The China FDA has recently promulgated the Provisions on the Food and Drug Administrative Penalty Procedure.
King & Wood Mallesons
The Revised Regulations will come into effective on 1 June 2014, presenting some major changes.
Benesch Law
On December 26, 2013, the Commission promulgated Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry Circular [2013] No. 49.
MWE China Law Offices
The State Council of the Chinese Central Government unveiled a revised Regulation on the Supervision and Administration of Medical Devices.
Most Popular Recent Articles
Vaish Associates Advocates
The food processing industry one of the largest industries in India is widely recognized as a 'sunrise industry' in India having huge potential for uplifting the agricultural economy, creation of large scale processed food manufacturing and food chain facilities, and the resultant generation of employment and export earnings.
Singh & Associates
Clinical research is the key to the discovery of latest diagnostic methods and to develop modern drugs for treatment of diseases.
Singh & Associates
With the objective to improvise and endow with the basic health care and availability of basic medicines at an affordable price across the country, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, , notified the Drug (Prices Control) Order 2013("DPCO 2013") in May 2013, which may fluctuate the pricing of 348 essential medicines.
Singh & Associates
In the last few years, the Indian pharmaceutical sector has seen an immense growth both in terms of domestic and international stratum.
Singh & Associates
Hon'ble Apex Court has recently awarded a historic verdict having a major impact on medical negligence and standard of medical care in India.
Ropes & Gray LLP
On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.
Vaish Associates Advocates
"Clinical Trials" and debates associated with it have been in headlines since past few months pursuant to the strict view taken by the apex court on the matter.
Singh & Associates
Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
Vaish Associates Advocates
The Indian Medical Device industry has shown remarkable variation in its synthesis of demand and supply.
Hunt & Hunt
Creators in the gourmet food industry could better protect their products using existing legal rights and protections.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter